期刊文献+

急性上呼吸道感染使用抗菌药物情况调查 被引量:5

Survey of Antibacterial Drug Used in Acute Upper Respiratory Tract Infection
下载PDF
导出
摘要 目的了解本院伴有发热的上呼吸道感染患者抗菌药物使用情况。方法于2011年1-8月期间搜集来我院就诊的伴有发热的上呼吸道感染患者1 469例的门诊病历及随访资料,对其治疗情况进行分析。结果该1 469例患者中使用抗菌药物者826例,占患者总人数的56.23%,其中头孢菌素使用率最高,达54.12%,其次为喹诺酮类和大环内酯类抗菌药;血常规及胸片检查率分别为2.31%和0.54%,平均治疗费用仅26.15元,治疗有效率99.00%。结论本院抗菌药物使用率较高,易造成耐药菌株的出现,但以较低廉的价格,达到了较好的治疗效果,在上呼吸道感染的治疗中发挥了积极的作用。 Objective To have a knowledge about antibacterial drugs used for patients with upper respiratory tract infection with fever in our hospital.Method Medical records and follow-up data of 1469 patients with upper respiratory tract infection with fever in our hospital were collected from January 2011 to August 2011 and their treatments were analyzed.Results Among the 1 469 patients,there were 826 ones using antibacterial drugs,which accounted for 56.23% of the total patients,wherein the usage rate of cephalosporin came first,reaching as high as 54.12%,followed by quinolones and macrolides antibacterial drugs.The examination rate of routine blood test and chest radiograph was 2.31% and 0.54% respectively.Average cost of treatment was only 26.15 Yuan,but the effective rate of treatment was 99.00%.Conclusion The utilization rate of antibacterial drugs is relatively high in our hospital,which could easily lead to drug-resistant strains.However,these antibacterial drugs achieve good treatment effects with cheap prices and play a positive role in treating upper respiratory tract infection.
出处 《保健医学研究与实践》 2012年第1期47-47,50,共2页 Health Medicine Research and Practice
关键词 上呼吸道感染 抗菌药物 Upper respiratory tract Infection Antibacterial drug
  • 相关文献

参考文献5

二级参考文献23

  • 1吴礼襄,萧正伦,黎毅敏.MRSA呼吸系统医院感染的分子流行病学调查[J].中华医院感染学杂志,2004,14(4):453-457. 被引量:76
  • 2邓旭,高赟,张艳,王素梅.临床标本细菌分布及耐药性分析[J].中华医院感染学杂志,2007,17(7):888-890. 被引量:28
  • 3[1]Ariza J,Pujol M.Nosocomial antibiotic resistance in GNB at the ICUs[J].Clin Pulmon Medi,2004,2(11):71-83.
  • 4[3]Ruiz J.Mechanisms of resistance to quinolones:target alterations,decreased accumulation and DNA gyrase protection[J].J Antimicrob Chemother,2003,51(5):1109-1117.
  • 5[4]National Committee Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[S].NCCLS,2004.1-159.
  • 6[5]Dashti AA,Paton R,Amyes SG.Linkage of ciprofloxacin resistance with a single genotypic cluster of Klebsiella pneumoniae[J].Int J Antimicrob Agents,2006,27(1):73-76.
  • 7[7]Fendukly F,Karlsson I,Hanson HS,et al.Patterns of mutations in target genes in septicemia isolatates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin[J].APMIS,2003,111(9):857-866.
  • 8[8]Woodford N,Johnson AP.Molecular bacteriology:protocols and clinical applications[M].New Jersey:Human Press,2001.617-639.
  • 9Neonakis IK, Samonis G, Messaritakis H, et al. Resistance status and evolution trends of Klebsiella pneumoniae isolates in auniversity hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy, 2010, 56: 448- 452.
  • 10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Fifteenth Informational Supplement. CLSI document M100-S17. Wayne Pennsylvania, 2007.

共引文献9

同被引文献52

  • 1陈琦,王君丽,尹娜,潘岳松,王娜,李蔚东,胡琳琳,郝晓宁,何永洁,孙力光,吴永浩,梁万年.北京市社区卫生服务机构实施收支两条线管理的财务收支变化分析[J].中国全科医学,2009,12(11):931-933. 被引量:9
  • 2王君丽,尹娜,陈琦,潘岳松,王娜,李蔚东,胡琳琳,郝晓宁,何永洁,孙力光,吴永浩,梁万年.北京市社区卫生服务机构实施收支两条线管理对机构服务质量的影响分析[J].中国全科医学,2009,12(11):934-937. 被引量:4
  • 3陶仲为.呼吸道细菌感染的抗生素治疗[J].中国实用内科杂志,2005,25(2):112-114. 被引量:29
  • 4王霞,单毓兰,朱广春.医院感染病原菌1800株耐药性分析[J].实用医药杂志,2006,23(2):204-206. 被引量:2
  • 5谢军平,吴玉海,冯玲玲.710株致病菌的耐药性分析[J].医药导报,2006,25(3):261-262. 被引量:3
  • 6金有豫.药理学[M].5版.北京:人民卫生出版社,2002:249-250.
  • 7Souli M, Galani I, Antoniadou. An outbreak of in- fection due to beta- Lactamase Klebsiella pneumoni- ae Carbapenemase 2- producing K. pneumoniae in a Greek University Hospital molecular characteriza- tion, epidemiology, anet outcomes[J]. Clinical Infec- tious Diseases, 2010, 50 (3) .. 786 - 788.
  • 8Borer A, Saidel- Odes L, Eskira S, et al. Risk fac- tors for developing clinical infection with carbapeflem - resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem- resistant K pneumonia[J]. American Journal of Infection Con- trol, 2012, 40(5) ..598 - 601.
  • 9Wenstrom K D,Owen J ,Chu D C,et at. Alpha- feto- protein, free beta- human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple- marker screening test for fetal Down syndrome [J]. Am J Obstet Gynecol, 2010,177(5) :987 - 991.
  • 10Borer A, Saidel-Odes L. Eskira S, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem- resistant K pneumonia. American Journal of Infection Control, 2012, 40(5):598-601.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部